ABSTRACT
AIM: To analyze the correlation between the elevated sensitivity of drug resistant breast cancer cells to the action of lymphokine-activated lymphocytes (LAK) and expression of E-cadherin and other marker proteins by cancer cells and lymphocytes. METHODS: Breast tumor explants were cultured with autologous lymphocytes in double diffusion chambers. The results were evaluated by morphological criteria of explants growth. Expression level of proteins on tumor cells was analyzed using immunohistochemical method on paraffin embedded sections, and by indirect immunofluorescence - on lymphocytes. RESULTS: Significant decrease of E-cadherin expression and significant increase of nuclear antigen of proliferating cells expression have been detected on drug resistant malignant human breast tumor (DRHBT) cells compared with drug sensitive breast tumor (DSHBT) cells. Autologous LAK possessed the highest antitumor activity against DRHBT cells that was associated with high expression level of soybean lectin receptor. CONCLUSION: Malignant drug resistant tumors are characterized by reverse relation between E-cadherin expression level and their proliferative activity. Marked antitumor action of LAK against these tumors is associated with high expression level of soybean lectin receptor on the lymphocytes.
Subject(s)
Breast Neoplasms/immunology , Cadherins/biosynthesis , Drug Resistance, Neoplasm/immunology , Killer Cells, Lymphokine-Activated/immunology , Receptors, Mitogen/metabolism , Biomarkers, Tumor/analysis , Breast Neoplasms/metabolism , Female , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Killer Cells, Lymphokine-Activated/metabolismABSTRACT
A study was made into the functional status of hypophysis, adrenal cortex, ovaries, and thyroid gland in patients with kraurosis and leukoplakia vulvae. The above patients demonstrated profound disturbances in the system hypophysis-ovaries, that attest to the need for applying corrective therapies to treat the disturbed hormonal homeostasis.
Subject(s)
Homeostasis , Hormones/blood , Leukoplakia/blood , Vulvar Lichen Sclerosus/blood , Vulvar Neoplasms/blood , Aged , Female , Humans , Middle Aged , RadioimmunoassaySubject(s)
Breast Neoplasms/diagnosis , Fibroadenoma/diagnosis , Iris , Precancerous Conditions/diagnosis , Adolescent , Adult , Aged , Diagnosis, Differential , Eye Diseases/diagnosis , Female , Humans , Middle AgedSubject(s)
Breast Neoplasms , Lung Neoplasms/secondary , Adult , Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/physiopathology , Female , Humans , Menopause , Middle Aged , Prognosis , Prolactin/blood , Respiration , Risk FactorsABSTRACT
Patients with cancer of the vulva showed significant disorders of pituitary adrenal cortex, ovarian and thyroid function. This requires carrying out corrective hormone therapy with the purpose of increasing the efficiency of combined treatment.
Subject(s)
Vulvar Neoplasms/metabolism , Adrenal Cortex/metabolism , Aged , Female , Hormones/blood , Humans , Middle Aged , Ovary/metabolism , Pituitary Gland/metabolism , Thyroid Gland/metabolism , Vulvar Neoplasms/bloodSubject(s)
Abortion, Induced , Breast Neoplasms/metabolism , Endocrine Glands/metabolism , Adult , Breast Neoplasms/blood , Female , Hormones/blood , Humans , Pregnancy , Time FactorsABSTRACT
The study included 157 patients with edematous-infiltrative breast cancer. Thermochemo- and thermoradiotherapy were shown to modify (increase) cancer cell sensitivity to antitumor treatment and thus improve tumor response.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/therapy , Edema/therapy , Hyperthermia, Induced , Adult , Aged , Breast Neoplasms/complications , Breast Neoplasms/mortality , Combined Modality Therapy , Drug Therapy, Combination , Edema/etiology , Female , Glucose/administration & dosage , Hormones/therapeutic use , Humans , Hyperthermia, Induced/methods , Magnetics/therapeutic use , Middle Aged , RadiotherapyABSTRACT
The paper discusses results of three-year follow-up of breast cancer patients keeping to a low-calorie diet after radical mastectomy and chemotherapy. The diet was planned according to age, energy expenditures and body weight and was aimed at a 15% decrease in the total caloricity as compared to corresponding individually-tailored norms for healthy people. This was achieved by reduction in fat (by 30%) and carbohydrates (by 9%). To assure the diet on the domiciliary basis, patients were provided with a table of nutrients for all food products available. Regular examination failed to show any adverse effects of the dietary restrictions on the general status of patients. However, an inhibiting effect of the diet on progression of disease was established, with recurrence being registered in 25% of controls (in 13 out of 52 patients) and only 7% of the study group (in 4 out of 56 cases).
Subject(s)
Breast Neoplasms/diet therapy , Energy Intake , Adult , Aged , Breast Neoplasms/pathology , Combined Modality Therapy , Female , Humans , Middle Aged , Neoplasm Metastasis , Neoplasm Staging , Postoperative Care , Prognosis , Remission Induction , Weight LossABSTRACT
beta-Casein genes expression in breast epithelium was studied in male patients with various forms of gynecomastia and cancer. Blood serum levels of pituitary, sex and glucocorticoid hormones were assayed in 29 patients with gynecomastia and 22 cases of breast cancer, and in 25 of them beta-casein genes expression was evaluated additionally. Activation of the above genes was established in the tissues studied. Their level proved to be in a correlation with that of prolactin.
Subject(s)
Breast Neoplasms/genetics , Caseins/genetics , Gene Expression Regulation, Neoplastic/genetics , Gene Expression Regulation/genetics , Gynecomastia/genetics , Homeostasis/genetics , Adult , Breast Neoplasms/blood , DNA/genetics , DNA, Neoplasm/genetics , Estrogens/blood , Gonadotropins, Pituitary/blood , Gynecomastia/blood , Humans , Hydrocortisone/blood , Male , Middle Aged , Testosterone/bloodABSTRACT
It was established that male patients with breast cancer showed significant disorders of the functional state of the pituitary, adrenal cortex and gonads. This may be significant for the efficacy of combined treatment.
Subject(s)
Adrenal Cortex/physiopathology , Breast Neoplasms/physiopathology , Pituitary Gland/physiopathology , Testis/physiopathology , Adrenal Cortex Hormones/blood , Breast Neoplasms/blood , Breast Neoplasms/urine , Gonadal Steroid Hormones/analysis , Humans , Male , Pituitary Hormones/bloodABSTRACT
Patients with gynecomastia revealed simultaneous increase in blood levels of estrogens, glucocorticoids and pituitary (first of all, gonadotropic) hormones associated with a decrease in blood-androgen concentration. Such combination of disturbances may account for hyperplasia of the male breast.
Subject(s)
Adrenal Cortex/physiopathology , Gynecomastia/physiopathology , Pituitary Gland/physiopathology , Testis/physiopathology , 17-Ketosteroids/blood , Adult , Androsterone/blood , Dehydroepiandrosterone/blood , Estradiol/blood , Estriol/blood , Etiocholanolone/blood , Gonadotropins, Pituitary/blood , Gynecomastia/blood , Humans , Male , Middle Aged , SpectrophotometryABSTRACT
An analysis of the activity of pituitary-adrenal and sympathetic-adrenal systems in patients with cancer of the digestive canal and lungs with consideration of age, sex and stage of the disease indicates that not age but the development of the tumour process is the leading factor in disorders of the neuroendocrine homeostasis. Therapeutic measures are discussed.
Subject(s)
Aging/physiology , Digestive System Neoplasms/physiopathology , Lung Neoplasms/physiopathology , Pituitary-Adrenal System/physiopathology , Sympathetic Nervous System/physiopathology , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Neurosecretory Systems/physiopathologySubject(s)
Breast Neoplasms/metabolism , Receptors, Cell Surface/metabolism , Antineoplastic Agents/therapeutic use , Breast Neoplasms/analysis , Breast Neoplasms/drug therapy , Estrogens/metabolism , Female , Humans , Prognosis , Receptors, Cell Surface/analysis , Receptors, Cell Surface/drug effects , Receptors, Estrogen/analysis , Receptors, Estrogen/drug effects , Receptors, Estrogen/metabolism , Receptors, Progesterone/analysis , Receptors, Progesterone/drug effects , Receptors, Progesterone/metabolism , Remission InductionABSTRACT
Long-term results of treatment of colorectal cancer versus levels of 17-ketosteroids, 17-ketogenic steroids, adrenaline and norepinephrine in diurnal urine were evaluated in 116 patients. Normal or slightly elevated urine-corticosteroid and catecholamine levels were shown to correlate with good prognosis, particularly, in cases with normal excretion of all (or almost all) hormones studied and their normal ratios.
Subject(s)
Adrenal Cortex Hormones/urine , Catecholamines/urine , Colonic Neoplasms/urine , Rectal Neoplasms/urine , Adenocarcinoma/mortality , Adenocarcinoma/therapy , Adenocarcinoma/urine , Adenocarcinoma, Mucinous/mortality , Adenocarcinoma, Mucinous/therapy , Adenocarcinoma, Mucinous/urine , Adult , Colonic Neoplasms/mortality , Colonic Neoplasms/therapy , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Prognosis , Rectal Neoplasms/mortality , Rectal Neoplasms/therapySubject(s)
Adrenal Glands/physiopathology , Esophageal Neoplasms/therapy , Stomach Neoplasms/therapy , Sympathetic Nervous System/physiopathology , Adult , Aged , Combined Modality Therapy , Esophageal Neoplasms/physiopathology , Female , Gastrectomy , Humans , Male , Middle Aged , Postoperative Period , Preoperative Care , Stomach Neoplasms/physiopathologyABSTRACT
The study was concerned with the functional condition of the sympatho-adrenal system in 80 patients with cancer of the esophagus and proximal part of the stomach who had undergone surgery and received combined treatment, coupled with measures aimed at correcting the sympatho-adrenal system in some cases. Treatment with phenformin, decaris and S-methylmethionine was shown to produce a favorable effect on certain stages of catecholamine synthesis and metabolism as well as on immunologic indexes and hemodynamic stability.
Subject(s)
Adrenal Medulla/physiopathology , Esophageal Neoplasms/physiopathology , Stomach Neoplasms/physiopathology , Sympathetic Nervous System/physiopathology , Adrenal Medulla/drug effects , Adult , Aged , Catecholamines/metabolism , Combined Modality Therapy , Epinephrine , Esophageal Neoplasms/immunology , Esophageal Neoplasms/surgery , Esophageal Neoplasms/therapy , Esophagus/surgery , Female , Gastrectomy , Humans , Immunoglobulin M/analysis , Levamisole/therapeutic use , Male , Middle Aged , Phenformin/therapeutic use , Rosette Formation , Stomach Neoplasms/immunology , Stomach Neoplasms/surgery , Stomach Neoplasms/therapy , Sympathetic Nervous System/drug effects , Vitamin U/therapeutic useABSTRACT
Excretion of corticosteroids, levels of 11-OCS in blood plasma, tests with dexasone and clinical evaluation of the pituitary-adrenal system function were studied in 354 patients with carcinomas of the esophagus and proximal stomach division. Some degree of hypocorticism with a decrease in the 11-OCS level in blood plasma and lowered excretion of corticosteroids in the urine were found in 71% of patients. These variations are accompanied by lowered hypothalamus sensitivity to dexasone. Similar disturbances though less pronounced are determined in the precancerous states and in the remote periods after operation.
Subject(s)
Esophageal Neoplasms/physiopathology , Pituitary-Adrenal System/physiopathology , Stomach Neoplasms/physiopathology , 17-Hydroxycorticosteroids/blood , 17-Hydroxycorticosteroids/urine , 17-Ketosteroids/blood , 17-Ketosteroids/urine , Adult , Aged , Dexamethasone , Female , Humans , Male , Middle Aged , Pituitary-Adrenal Function TestsABSTRACT
Patients with esophageal and gastric cancer show a decreased diurnal excretion of DOPA matched by a considerable drop in the urine levels of catecholamines and their main metabolites as compared with healthy subjects. This points to a severe inhibition of synthesis and metabolism of catecholamines at all stages. Tumor process progression is accompanied by an ever-increasing inhibition of sympatho-adrenal system function. Simultaneously, disorders develop in the functioning of the cholinergic structures of the nervous system.